Alaunos Therapeutics, Inc. (TCRT) quarterly income statement — complete revenue, gross profit & net income history
Alaunos Therapeutics, Inc. (TCRT) annual income statement — 25-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 0 | 0 | 3K | 0 | 0 | 2K | 4K | 0 | 4K | 1K | 1K | 0 | 4K | 0 | 11K | 2.91M | 0 | 0 | 0 | 398K |
| Revenue Growth % | - | -100% | -25% | - | -100% | 100% | 300% | - | 0% | - | -90.91% | -100% | - | - | - | 631.41% | - | - | - | - |
| Cost of Goods Sold | 9K | 8K | 361K | 469K | 185K | 347K | 0 | 143K | 180K | 2K | 933K | 1.06M | 5.19M | 696K | 3.11M | 691K | 685K | 689K | 705K | 0 |
| COGS % of Revenue | - | - | 12033.33% | - | - | 17350% | - | - | 4500% | 200% | 93300% | - | 129650% | - | 28245.45% | 23.74% | - | - | - | - |
| Gross Profit | -9K | -8K | -358K | -469K | -185K | -345K | 4K | -143K | -176K | -1K | -932K | -1.06M | -5.18M | -696K | -3.1M | 2.22M | -685K | -689K | -705K | 398K |
| Gross Margin % | - | - | -11933.33% | - | - | -17250% | 100% | - | -4400% | -100% | -93200% | - | -129550% | - | -28145.45% | 76.26% | - | - | - | 100% |
| Gross Profit Growth % | 95.14% | 97.68% | -9050% | -227.97% | -5.11% | -34400% | 100.43% | 86.56% | 96.6% | 99.86% | 69.9% | -147.93% | -656.5% | -1.02% | -339.15% | 457.79% | -0.88% | -27.59% | - | - |
| Operating Expenses | 943K | 1M | 549K | 718K | 854K | 747K | 759K | 1.01M | 990K | 1.74M | 7.02M | 6.17M | 2.8M | 8.98M | 5.42M | 10.48M | 8.68M | 8.4M | 9.49M | 22.69M |
| OpEx % of Revenue | - | - | 18300% | - | - | 37350% | 18975% | - | 24750% | 174100% | 701700% | - | 70000% | - | 49318.18% | 360.15% | - | - | - | 5702.01% |
| Selling, General & Admin | 564K | 585K | 549K | 718K | 854K | 747K | 845K | 1.01M | 990K | 1.61M | 2.43M | 2.51M | 3.04M | 2.47M | 2.92M | 2.59M | 2.74M | 2.82M | 1.39M | 8.17M |
| SG&A % of Revenue | - | - | 18300% | - | - | 37350% | 21125% | - | 24750% | 161500% | 242800% | - | 76125% | - | 26590.91% | 89.01% | - | - | - | 2053.52% |
| Research & Development | 388K | 427K | 361K | 469K | 185K | 347K | -86K | 143K | 180K | 126K | 933K | 3.66M | 5.19M | 6.5M | 5.61M | 7.89M | 5.94M | 5.58M | 8.1M | 14.52M |
| R&D % of Revenue | - | - | 12033.33% | - | - | 17350% | -2150% | - | 4500% | 12600% | 93300% | - | 129650% | - | 50972.73% | 271.14% | - | - | - | 3648.49% |
| Other Operating Expenses | -9K | -8K | -361K | -469K | -185K | -347K | 0 | -143K | -180K | 0 | 1000K | 0 | -1000K | 0 | -1000K | 0 | 0 | 0 | 0 | 7K |
| Operating Income | -952K | -1.01M | -907K | -1.19M | -1.04M | -1.09M | -755K | -1.15M | -1.17M | -1.74M | -7.95M | -7.23M | -7.98M | -9.67M | -8.52M | -8.26M | -9.37M | -9.09M | -10.19M | -22.3M |
| Operating Margin % | - | - | -30233.33% | - | - | -54600% | -18875% | - | -29150% | -174200% | -794900% | - | -199550% | - | -77463.64% | -283.89% | - | - | - | -5602.01% |
| Operating Income Growth % | 8.37% | 7.33% | -20.13% | -3.22% | 10.89% | 37.31% | 90.5% | 84.1% | 85.39% | 81.99% | 6.71% | 12.46% | 14.78% | -6.46% | 16.39% | 62.94% | 58.63% | 57.87% | 55.25% | -9.72% |
| EBITDA | -943K | -1M | -900K | -1.16M | -1.04M | -1.07M | -756K | -1.13M | -1.17M | -1.74M | -7.71M | -6.17M | -7.28M | -8.98M | -7.83M | -7.57M | -8.68M | -8.4M | -9.49M | -21.62M |
| EBITDA Margin % | - | - | -30000% | - | - | -53650% | -18900% | - | -29125% | -174000% | -770800% | - | -182075% | - | -71154.55% | -260.15% | - | - | - | -5432.91% |
| EBITDA Growth % | 9.2% | 6.43% | -19.05% | -2.84% | 10.86% | 38.33% | 90.19% | 81.73% | 84% | 80.62% | 1.52% | 18.53% | 16.1% | -6.91% | 17.49% | 64.98% | 60.47% | 60.06% | 57.56% | -8.1% |
| D&A (Non-Cash Add-back) | 9K | 8K | 7K | 0 | 499 | 0 | -1K | 0 | 1K | 2K | 241K | 1.06M | 699K | 696K | 694K | 691K | 685K | 689K | 705K | 673K |
| EBIT | -952K | -1.01M | -893K | -1.16M | -1.05M | -1.07M | -742K | -1.13M | -1.13M | -1.68M | -3.36M | -8.48M | -8.23M | -9.2M | -6.02M | -8.01M | -9.19M | -9.11M | -11.06M | -22.29M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.07M | -853K | -888K | -841K | -740K | -683K | -738K | -444K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.07M | 853K | 888K | 841K | 740K | 683K | 738K | 444K |
| Other Income/Expense | 0 | 6K | 14K | 28K | -12K | 19K | 13K | 23K | 37K | 60K | 106K | -1.24M | -791K | -376K | -638K | -587K | -566K | -703K | -1.6M | -437K |
| Pretax Income | -952K | -1.01M | -893K | -1.16M | -1.05M | -1.07M | -742K | -1.13M | -1.13M | -1.68M | -7.84M | -8.48M | -8.77M | -10.05M | -9.16M | -8.85M | -9.93M | -9.79M | -11.79M | -22.73M |
| Pretax Margin % | - | - | -29766.67% | - | - | -53650% | -18550% | - | -28225% | -168200% | -784300% | - | -219325% | - | -83263.64% | -304.05% | - | - | - | -5711.81% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -952K | -1.01M | -893K | -1.16M | -1.05M | -1.07M | -742K | -1.13M | -1.13M | -1.68M | -7.84M | -8.48M | -8.77M | -10.05M | -9.16M | -8.85M | -9.93M | -9.79M | -11.79M | -22.73M |
| Net Margin % | - | - | -29766.67% | - | - | -53650% | -18550% | - | -28225% | -168200% | -784300% | - | -219325% | - | -83263.64% | -304.05% | - | - | - | -5711.81% |
| Net Income Growth % | 9.42% | 6.24% | -20.35% | -2.84% | 6.91% | 36.21% | 90.54% | 86.7% | 87.13% | 83.26% | 14.37% | 4.24% | 11.67% | -2.66% | 22.34% | 61.07% | 56.19% | 54.59% | 48.21% | -11.9% |
| Net Income (Continuing) | -952K | -1.01M | -893K | -1.16M | -1.05M | -1.07M | -742K | -1.13M | -1.13M | -1.68M | -7.84M | -8.48M | -8.77M | -10.05M | -9.16M | -8.85M | -9.93M | -9.79M | -11.79M | -22.73M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.41 | -0.59 | -0.40 | -0.55 | -0.63 | -0.67 | -0.46 | -0.70 | -0.71 | -1.05 | -4.90 | -5.30 | -5.49 | -5.85 | -6.58 | -6.58 | -6.84 | -7.32 | -8.24 | -15.89 |
| EPS Growth % | 34.92% | 11.94% | 13.04% | 21.43% | 11.27% | 36.19% | 90.61% | 86.79% | 87.07% | 82.05% | 25.53% | 19.45% | 19.74% | 20.08% | 20.15% | 58.59% | 56.87% | 51.56% | 48.6% | -10.96% |
| EPS (Basic) | -0.41 | -0.59 | -0.40 | -0.55 | -0.63 | -0.67 | -0.46 | -0.70 | -0.71 | -1.05 | -4.90 | -5.30 | -5.49 | -5.85 | -6.58 | -6.58 | -6.84 | -7.32 | -8.24 | -15.89 |
| Diluted Shares Outstanding | 2.43M | 1.95M | 1.95M | 2.18M | 1.68M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.49M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M |
| Basic Shares Outstanding | 2.43M | 1.95M | 1.95M | 2.18M | 1.68M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.49M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |